Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT06704191

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

MC240502: Cancer CARE (Connected Access and Remote Expertise) Beyond Walls In-home iNtraVesIcal ThErapy (INVITE) Study - A Phase Ib/II, Single-Arm Trial of Delivering Intravesical Therapy for Bladder Cancer in Patients' Homes

Sponsor: Mayo Clinic

Conditions Non-Muscle Invasive Bladder Carcinoma Stage 0a Bladder Cancer AJCC v8 Stage 0is Bladder Cancer AJCC v8 Stage I Bladder Cancer AJCC v8

Interventions BCG Solution Cystoscopy Docetaxel Gemcitabine Home Health Encounter Mitomycin Questionnaire Administration

Updated 7 times since 2024 Last updated: Sep 17, 2025 Started: Apr 21, 2025 Primary completion: Jun 6, 2026 Completion: Jun 6, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Non-Muscle Invasive Bladder Carcinoma and Stage 0a Bladder Cancer AJCC v8, this trial is actively recruiting participants. The trial is conducted by Mayo Clinic and has accumulated 7 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Recruiting PHASE1/PHASE2
Aug 2025 — Oct 2025 [monthly]

Recruiting PHASE1/PHASE2
Jun 2025 — Aug 2025 [monthly]

Recruiting PHASE1/PHASE2
May 2025 — Jun 2025 [monthly]

Recruiting PHASE1/PHASE2

Status: Not Yet Recruiting → Recruiting
Mar 2025 — May 2025 [monthly]

Not Yet Recruiting PHASE1/PHASE2

▶ Show 2 earlier versions

Jan 2025 — Mar 2025 [monthly]

Not Yet Recruiting PHASE1/PHASE2
Dec 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE1/PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
National Center for Advancing Translational Sciences (NCATS)

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jacksonville, United States